February 12, 2026

Curbing Drug-Related Halitosis for Closer Moments

Individuals who have drug-related halitosis may need to take additional steps to prioritize oral health before intimate encounters.

Conexiant

February 12, 2026

Connecting the Diagnostic Dots in HIES

Clinical case report highlights how classic features of STAT3 hyper-IgE syndrome can be routinely missed in pediatric practice

Conexiant

February 10, 2026

When Obesity Meets Infection Risk

Researchers analyze data from Finnish cohorts and the UK Biobank to examine how body mass index relates to severe infections and their global burden.

Conexiant

February 04, 2026

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

KFF Health News

January 27, 2026

Mpox Sequelae Persist 11 to 18 Months After Infection 

Study supports follow-up and multidisciplinary care for persistent physical and psychosocial effects 

Conexiant

January 27, 2026

CDC Database Pauses Raise Concerns

Researchers review the scope and characteristics of unexplained pauses in CDC surveillance databases and examine potential implications for public health monitoring.

Conexiant

January 27, 2026

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Conexiant

January 21, 2026

The Topical Drug Delivery Challenge

From skin penetration to stability and spreadability; here’s what to consider if you want to develop a topical therapeutic

The Medicine Maker

April 29, 2024

First Death From Alaskapox Reported

Alaska health officials warned of the risk of Alaskapox in the wake of the first death from the disease in January 2024.

Conexiant